Cargando…

Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy

BACKGROUND: The diagnostic efficacy regarding prostate cancer (PC) detection by manually operated in-bore magnetic resonance imaging (MRI) targeted prostate biopsy (MO-MRGB) versus robot-assisted in-bore MRI targeted prostate biopsy (RA-MRGB) is lacking evidence. OBJECTIVE: We hypothesized that the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandahl, Mads, Sandahl, Kristian Juul, Marinovskij, Edvard, Nielsen, Tomas Frahm, Sørensen, Karina Dalsgaard, Borre, Michael, Ulhøi, Benedicte Parm, Pedersen, Bodil Ginnerup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257664/
https://www.ncbi.nlm.nih.gov/pubmed/35813252
http://dx.doi.org/10.1016/j.euros.2022.05.002
_version_ 1784741385801302016
author Sandahl, Mads
Sandahl, Kristian Juul
Marinovskij, Edvard
Nielsen, Tomas Frahm
Sørensen, Karina Dalsgaard
Borre, Michael
Ulhøi, Benedicte Parm
Pedersen, Bodil Ginnerup
author_facet Sandahl, Mads
Sandahl, Kristian Juul
Marinovskij, Edvard
Nielsen, Tomas Frahm
Sørensen, Karina Dalsgaard
Borre, Michael
Ulhøi, Benedicte Parm
Pedersen, Bodil Ginnerup
author_sort Sandahl, Mads
collection PubMed
description BACKGROUND: The diagnostic efficacy regarding prostate cancer (PC) detection by manually operated in-bore magnetic resonance imaging (MRI) targeted prostate biopsy (MO-MRGB) versus robot-assisted in-bore MRI targeted prostate biopsy (RA-MRGB) is lacking evidence. OBJECTIVE: We hypothesized that the detection rates (DRs) for PC of MO-MRGB and RA-MRGB were similar and aimed to compare these. DESIGN, SETTING, AND PARTICIPANTS: We prospectively included all patients who received in-bore MRI targeted prostate biopsy (MRGB) of the prostate in the Central Denmark Region from August 2014 to February 2020. From August 2014, MO-MRGB was used, and from March 2018, RA-MRGB was preferred. Referral to in-bore MRGB was based on multiparametric MRI (mpMRI). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We compared PC DRs of MO-MRGB and RA-MRGB with Pearson’s chi-square test. We made three binary regression models and calculated the risk difference (RD) of PC between the in-bore MRGB systems. RESULTS AND LIMITATIONS: A total of 3107 patients were referred to mpMRI, and 884 (28%) patients went on to receive in-bore MRGB. The MO-MRGB and RA-MRGB systems were used in 505 (57%) and 379 (43%) patients, respectively. Taking clinically relevant covariates into account, we found no statistically significant difference in PC DRs between MO-MRGB and RA-MRGB (72% vs 73%, RD 1%, 95% confidence interval –4% to 7%, p = 0.6). The main limitation was a shift in population characteristics. CONCLUSIONS: We did not see evidence of an effect on the DR or the RD for PC when we compared MO-MRGB with RA-MRGB. Cost effectiveness should be considered carefully when choosing the MRGB system. PATIENT SUMMARY: We compared two magnetic resonance imaging guided prostate tissue sampling systems regarding prostate cancer (PC) detection. One system was manually operated, and the other system was robot assisted. Comparing the systems, we found no evidence of a difference in their ability to detect PC.
format Online
Article
Text
id pubmed-9257664
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92576642022-07-07 Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy Sandahl, Mads Sandahl, Kristian Juul Marinovskij, Edvard Nielsen, Tomas Frahm Sørensen, Karina Dalsgaard Borre, Michael Ulhøi, Benedicte Parm Pedersen, Bodil Ginnerup Eur Urol Open Sci Prostate Cancer BACKGROUND: The diagnostic efficacy regarding prostate cancer (PC) detection by manually operated in-bore magnetic resonance imaging (MRI) targeted prostate biopsy (MO-MRGB) versus robot-assisted in-bore MRI targeted prostate biopsy (RA-MRGB) is lacking evidence. OBJECTIVE: We hypothesized that the detection rates (DRs) for PC of MO-MRGB and RA-MRGB were similar and aimed to compare these. DESIGN, SETTING, AND PARTICIPANTS: We prospectively included all patients who received in-bore MRI targeted prostate biopsy (MRGB) of the prostate in the Central Denmark Region from August 2014 to February 2020. From August 2014, MO-MRGB was used, and from March 2018, RA-MRGB was preferred. Referral to in-bore MRGB was based on multiparametric MRI (mpMRI). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We compared PC DRs of MO-MRGB and RA-MRGB with Pearson’s chi-square test. We made three binary regression models and calculated the risk difference (RD) of PC between the in-bore MRGB systems. RESULTS AND LIMITATIONS: A total of 3107 patients were referred to mpMRI, and 884 (28%) patients went on to receive in-bore MRGB. The MO-MRGB and RA-MRGB systems were used in 505 (57%) and 379 (43%) patients, respectively. Taking clinically relevant covariates into account, we found no statistically significant difference in PC DRs between MO-MRGB and RA-MRGB (72% vs 73%, RD 1%, 95% confidence interval –4% to 7%, p = 0.6). The main limitation was a shift in population characteristics. CONCLUSIONS: We did not see evidence of an effect on the DR or the RD for PC when we compared MO-MRGB with RA-MRGB. Cost effectiveness should be considered carefully when choosing the MRGB system. PATIENT SUMMARY: We compared two magnetic resonance imaging guided prostate tissue sampling systems regarding prostate cancer (PC) detection. One system was manually operated, and the other system was robot assisted. Comparing the systems, we found no evidence of a difference in their ability to detect PC. Elsevier 2022-05-28 /pmc/articles/PMC9257664/ /pubmed/35813252 http://dx.doi.org/10.1016/j.euros.2022.05.002 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Prostate Cancer
Sandahl, Mads
Sandahl, Kristian Juul
Marinovskij, Edvard
Nielsen, Tomas Frahm
Sørensen, Karina Dalsgaard
Borre, Michael
Ulhøi, Benedicte Parm
Pedersen, Bodil Ginnerup
Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
title Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
title_full Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
title_fullStr Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
title_full_unstemmed Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
title_short Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
title_sort prostate cancer detection rate of manually operated and robot-assisted in-bore magnetic resonance imaging targeted biopsy
topic Prostate Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257664/
https://www.ncbi.nlm.nih.gov/pubmed/35813252
http://dx.doi.org/10.1016/j.euros.2022.05.002
work_keys_str_mv AT sandahlmads prostatecancerdetectionrateofmanuallyoperatedandrobotassistedinboremagneticresonanceimagingtargetedbiopsy
AT sandahlkristianjuul prostatecancerdetectionrateofmanuallyoperatedandrobotassistedinboremagneticresonanceimagingtargetedbiopsy
AT marinovskijedvard prostatecancerdetectionrateofmanuallyoperatedandrobotassistedinboremagneticresonanceimagingtargetedbiopsy
AT nielsentomasfrahm prostatecancerdetectionrateofmanuallyoperatedandrobotassistedinboremagneticresonanceimagingtargetedbiopsy
AT sørensenkarinadalsgaard prostatecancerdetectionrateofmanuallyoperatedandrobotassistedinboremagneticresonanceimagingtargetedbiopsy
AT borremichael prostatecancerdetectionrateofmanuallyoperatedandrobotassistedinboremagneticresonanceimagingtargetedbiopsy
AT ulhøibenedicteparm prostatecancerdetectionrateofmanuallyoperatedandrobotassistedinboremagneticresonanceimagingtargetedbiopsy
AT pedersenbodilginnerup prostatecancerdetectionrateofmanuallyoperatedandrobotassistedinboremagneticresonanceimagingtargetedbiopsy